HLN
Haleon plc · Healthcare · Drug Manufacturers - Specialty & Generic
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 142.53K | $1.29M | n/a | −1 |
| Q2 2026 | 103 | +5 | 528.15M | $4.87B | +8 | −4 |
| Q1 2026 | 100 | +1 | 506.60M | $5.01B | +6 | −6 |
| Q4 2025 | 99 | -2 | 494.67M | $4.94B | +1 | −2 |
| Q3 2025 | 16 | -1 | 341.18M | $3.06B | +1 | −3 |
| Q2 2025 | 15 | 0 | 306.18M | $3.18B | +2 | −2 |
| Q1 2025 | 13 | 0 | 210.33M | $2.16B | n/a | n/a |
| Q4 2024 | 13 | +1 | 208.23M | $1.99B | +2 | −1 |
| Q3 2024 | 11 | 0 | 206.41M | $2.18B | +2 | −2 |
| Q2 2024 | 11 | n/a | 210.64M | $1.74B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 180.17M | n/a | $1.49B | 0.9% | n/c | 1 | SEC ↗ |
| 2 | Fisher Asset Management ✦ | 13.97M | n/a | $115.37M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 6.11M | n/a | $50.43M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 4 | Citadel Advisors ✦ | 5.65M | n/a | $46.68M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | Two Sigma Investments ✦ | 2.10M | n/a | $17.34M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 1.30M | n/a | $10.74M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 548.00K | n/a | $4.53M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 312.83K | n/a | $2.58M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 200.64K | n/a | $1.66M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Bridgewater Associates ✦ | 189.56K | n/a | $1.57M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Tweedy, Browne ✦ | 95.61K | n/a | $789,730 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 618 tenedores, 559.47M acciones, $5.40B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.